Industry Veteran Robert Roman Joins GenTrust, Expanding Senior Advisor Team
Roman most recently served as president and CEO of MGO Private Wealth, where he has partnered with GenTrust for over a decade. Roman's clients include several successful entrepreneurs, as well as luminaries in the sports and entertainment industries.
GenTrust provides sophisticated, institutional-quality solutions to a select group of ultra-high-net-worth individuals and family offices. The firm was founded in 2011 by financial industry veterans
"Robert brings to GenTrust 25 years of advisory experience, an entrepreneurial spirit, and a fresh approach to private investments, which is complementary to our offerings," said Perez, principal and co-founder of GenTrust.
"I've known George, Jim and the GenTrust team for half of my professional career," Roman said. "GenTrust's sophisticated investment solutions have been a perfect fit for my clients, and l am excited to be joining for this next chapter in my career."
Roman spent his early career working at two large global wealth management firms. After more than a decade on
About GenTrust
GenTrust is an investment-focused, multi-family office delivering sophisticated, institutional-quality solutions to a select group of ultra-high-net-worth individuals and families. GenTrust also extends its investment capabilities and infrastructure to single family offices, independent registered investment advisors (RIAs), and other financial institutions seeking to enhance their investment offerings through the GenTrust CIO Partnership.
Founded in 2011, GenTrust has approximately
Note: Regulatory assets under management for GenTrust are as of
Media Contacts:
Newton Park PR, LLC
+1 847-507-2229
[email protected]
+1 773-710-7433
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/industry-veteran-robert-roman-joins-gentrust-expanding-senior-advisor-team-302583507.html
SOURCE GenTrust
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Tax Expert Sal Julian Details Which Itemized Deductions High-Income Individuals Lose Without Knowing It
- Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
- Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share